More recently, cryo-EM was used to resolve the structure of HER2 kinase in complex with a novel inhibitor, paving the way for next-generation therapies for HER2-positive breast cancer (Bornscheuer et al., 2012). This evidence concerns the gene ERBB2 and breast cancer.